Optimizing the Treatment of Complicated UTIs Podcast (2021)

This podcast episode aims to address the educational gaps surrounding complicated urinary tract infections (UTIs). The ability for urologic practitioners to diagnose, treat, and manage UTIs has evolved due to additional insights into the pathophysiology of complicated UTIs. There is a need to provide education on the adverse effects of antimicrobial therapy, rising rates of bacterial antimicrobial resistance, and the most effective treatment options for complicated UTIs. Treatment options, including the most current and safe antibiotic regimens, will be discussed.

ACKNOWLEDGEMENTS

This activity is supported by an independent educational grant from:

Spero Therapeutics

    Target Audience

    • Urologist
    • Resident
    • Advanced Practice Provider (Nurse Practitioners & Physician Assistants)

    Learning Objectives

    At the conclusion of this activity, participants will be able to:

    1. Differentiate between simple (uncomplicated) and complicated UTIs and broad differences in management strategies between these two type of infections.
    2. Review the current treatment options for complicated UTIs, including oral, and parenteral (intravenous and intramuscular) treatments.
    3. Define the similarities and differences between the various treatment options for complicated UTIs and incorporate shared decision making in UTI management
    4. Describe the concept of antibiotic stewardship, treating patients with the safest methods possible, thereby decreasing associated morbidity and adverse sequalae.
    Course summary
    Available credit: 
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Non-Physician Participation
    Course opens: 
    11/03/2021
    Course expires: 
    11/03/2022
    Rating: 
    0

    Education Council Disclosures

    PDF iconEducation Council Disclosures June 2021.pdf

    COI Review Work Group Disclosures

    PDF iconCOI Review Work Group Disclosures 2021.pdf

    AUA Office of Education Staff has nothing to disclose.

    Moderator(s)

    Jay Raman, MD,FACS

    has no relevant financial relationships to disclose at this time.
    Podcast Co-Host(s)

    A. Ackerman, MD, PHD

    has no relevant financial relationships to disclose at this time.

    METHOD OF PARTICIPATION: 

    Learners will participate in this online educational activity by listening to the podcast and completing the post-test and evaluation. To claim CME credit for this enduring material, learners must complete the post-test, passing with 80% accuracy, and submit the program evaluation.

    Estimated time to complete this activity: 0.50 hours

    Release Date: November, 2021
    Expiration Date: November, 2022

    ACCREDITATION: 

    The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    CREDIT DESIGNATION: 

    The American Urological Association designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    OTHER LEARNERS: 

    The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

    EVIDENCE BASED CONTENT: 

    It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

    AUA DISCLOSURE POLICY: 

    All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

    RESOLUTION OF IDENTIFIED CONFLICT OF INTEREST: 

    All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

    • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
    • Limit content to evidence with no recommendations
    • Introduction of a debate format with an unbiased moderator (point-counterpoint)
    • Inclusion of moderated panel discussion
    • Publication of a parallel or rebuttal article for an article that is felt to be biased
    • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
    • Divestiture of the relationship by faculty

    OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES: 

    The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

    Available Credit

    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Non-Physician Participation
    Please login or register to take this course.